Education
About Us
Working with TipRanks
Follow Us
Tong Ren Tang Technologies Co Class H (HK:1666)
:1666
1666 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$4.40 - HK$6.66
Previous CloseN/A
Volume468.00K
Average Volume (3M)1.71M
Market Cap
HK$6.13B
Enterprise ValueHK$6.70B
Total Cash (Recent Filing)HK$4.38B
Total Debt (Recent Filing)HK$2.43B
Price to Earnings (P/E)13.2
Beta0.89
Next Earnings
Mar 20, 2026EPS EstimateN/A
Last Dividend Ex-Date
Jun 16, 2025Dividend Yield4.1%
Share Statistics
EPS (TTM)0.28
Shares Outstanding628,704,000
10 Day Avg. Volume894,800
30 Day Avg. Volume1,705,540
Financial Highlights & Ratios
PEG Ratio-1.10
Price to Book (P/B)0.87
Price to Sales (P/S)0.86
P/FCF Ratio-39.37
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Tong Ren Tang Technologies Co News
1666 FAQ
What was Tong Ren Tang Technologies Co Class H’s price range in the past 12 months?
Tong Ren Tang Technologies Co Class H lowest stock price was HK$4.40 and its highest was HK$6.66 in the past 12 months.
What is Tong Ren Tang Technologies Co Class H’s market cap?
Tong Ren Tang Technologies Co Class H’s market cap is HK$6.13B.
When is Tong Ren Tang Technologies Co Class H’s upcoming earnings report date?
Tong Ren Tang Technologies Co Class H’s upcoming earnings report date is Mar 20, 2026 which is in 171 days.
How were Tong Ren Tang Technologies Co Class H’s earnings last quarter?
Tong Ren Tang Technologies Co Class H released its earnings results on Aug 26, 2025. The company reported HK$0.284 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.284.
Is Tong Ren Tang Technologies Co Class H overvalued?
According to Wall Street analysts Tong Ren Tang Technologies Co Class H’s price is currently Overvalued.
Does Tong Ren Tang Technologies Co Class H pay dividends?
Tong Ren Tang Technologies Co Class H pays a Annually dividend of HK$0.197 which represents an annual dividend yield of 4.1%. See more information on Tong Ren Tang Technologies Co Class H dividends here
What is Tong Ren Tang Technologies Co Class H’s EPS estimate?
Tong Ren Tang Technologies Co Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tong Ren Tang Technologies Co Class H have?
Tong Ren Tang Technologies Co Class H has 628,704,000 shares outstanding.
What happened to Tong Ren Tang Technologies Co Class H’s price movement after its last earnings report?
Tong Ren Tang Technologies Co Class H reported an EPS of HK$0.284 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.301%.
Which hedge fund is a major shareholder of Tong Ren Tang Technologies Co Class H?
Currently, no hedge funds are holding shares in HK:1666
Company Description
Tong Ren Tang Technologies Co Class H
Tong Ren Tang Technologies Co. Ltd. manufactures and sells Chinese medicine products in Mainland China and Hong Kong. The company also cultivates, purchases, and sells Chinese medicinal raw materials; produces and sells ointment, tea drinks, and foot care products; sells medicinal products; and provides medical research and development, advertisement, and Chinese medical consultation and treatment services. In addition, it is involved in the technological development and sale of biological products, Chinese and Western medicines, cosmetics, and healthcare products; wholesale and retail sale of Chinese medicines and healthcare products; and internal and external surgery, medical examination, and hospital management activities. Further, it produces and processes biochemical products; extracts and processes plants; and produces food and daily chemical products, and medical services. The company was founded in 1669 and is based in Beijing, the People's Republic of China.
Technical Analysis
Beijing Tong Ren Tang Chinese Medicine Co
―
China Traditional Chinese Medicine Holdings Co
―
Abbisko Cayman Limited
―
China Shineway Pharmaceutical Group Limited
―
Reliance Global Holdings Limited
―
Options Prices
Currently, No data available
---